Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children worldwide. But RSV doesn’t affect all children in the same way. In this article, pediatric pulmonologist Fabria Rezaee, MD, discusses her study that suggests air pollution may intensify RSV symptoms.
Groundbreaking Study Shows Important Functional Differences in Calcium Transport Molecule
There are no FDA-approved drugs to treat kids who get RSV. Cleveland Clinic researchers published the results of a groundbreaking pediatric study, which may lead to better treatments.
Restoring the Airway Epithelial Barrier to Fight RSV
A new study dissects the pathways involved in RSV-induced barrier disruption and examines how modifying the involved mechanisms could restore the barrier’s integrity.
Prenatal Exposure to Respiratory Syncytial Virus Found to Alter Postnatal Immunity
Cross-placenta viral transmission during the first trimester of pregnancy contributes to the development of asthma and other chronic respiratory problems, and may explain other postnatal conditions.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Airway Epithelial Barrier Dysfunction in Response to RSV
Cleveland Clinic Children’s continues research into RSV with goal of improving understanding of basic biology and aiding in design of new agents.